118 related articles for article (PubMed ID: 36933380)
1. Angelicin impedes the progression of glioblastoma via inactivation of YAP signaling pathway.
Wang M; Xing S; Jia J; Zeng W; Lei J; Qian Y; Xiong Z; Wang X; Cao L; Wang Y; Wang Y; Jiang Y; Huang Z
Biomed Pharmacother; 2023 May; 161():114462. PubMed ID: 36933380
[TBL] [Abstract][Full Text] [Related]
2. Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling.
Xu J; Sun S; Zhang W; Dong J; Huang C; Wang X; Jia M; Yang H; Wang Y; Jiang Y; Cao L; Huang Z
Front Pharmacol; 2022; 13():1027577. PubMed ID: 36532767
[TBL] [Abstract][Full Text] [Related]
3. Angelicin inhibits human lung carcinoma A549 cell growth and migration through regulating JNK and ERK pathways.
Li G; He Y; Yao J; Huang C; Song X; Deng Y; Xie S; Ren J; Jin M; Liu H
Oncol Rep; 2016 Dec; 36(6):3504-3512. PubMed ID: 27748898
[TBL] [Abstract][Full Text] [Related]
4. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
5. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway.
Ding X; Deng G; Liu J; Liu B; Yuan F; Yang X; Chen Q
Brain Res; 2019 Aug; 1717():117-126. PubMed ID: 30935831
[TBL] [Abstract][Full Text] [Related]
6. YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.
Vigneswaran K; Boyd NH; Oh SY; Lallani S; Boucher A; Neill SG; Olson JJ; Read RD
Clin Cancer Res; 2021 Mar; 27(5):1553-1569. PubMed ID: 33172899
[TBL] [Abstract][Full Text] [Related]
7. Valtrate, an iridoid compound in Valeriana, elicits anti-glioblastoma activity through inhibition of the PDGFRA/MEK/ERK signaling pathway.
Liu X; Hu Y; Xue Z; Zhang X; Liu X; Liu G; Wen M; Chen A; Huang B; Li X; Yang N; Wang J
J Transl Med; 2023 Feb; 21(1):147. PubMed ID: 36829235
[TBL] [Abstract][Full Text] [Related]
8. Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2-mediated signaling.
Sang Y; Hou Y; Cheng R; Zheng L; Alvarez AA; Hu B; Cheng SY; Zhang W; Li Y; Feng H
Neuro Oncol; 2019 Nov; 21(11):1423-1435. PubMed ID: 31232447
[TBL] [Abstract][Full Text] [Related]
9. Bisdemethoxycurcumin Induces Cell Apoptosis and Inhibits Human Brain Glioblastoma GBM 8401/
Hsia TC; Peng SF; Chueh FS; Lu KW; Yang JL; Huang AC; Hsu FT; Wu RS
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008959
[TBL] [Abstract][Full Text] [Related]
10. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
[TBL] [Abstract][Full Text] [Related]
11. Angelicin inhibits the growth and migration of triple-negative breast cancer cells.
I-Hsiao C; Chien-Yu C; Yu-Hsuan L; I-Fen C
Pak J Pharm Sci; 2023 Jan; 36(1):51-57. PubMed ID: 36967496
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1.
Zhang R; Luo H; Wang S; Chen W; Chen Z; Wang HW; Chen Y; Yang J; Zhang X; Wu W; Zhang SY; Shen S; Dong Q; Zhang Y; Jiang T; Lu D; Zhao S; You Y; Liu N; Wang H
Neuro Oncol; 2014 Nov; 16(11):1510-22. PubMed ID: 24951112
[TBL] [Abstract][Full Text] [Related]
14. YAP promotes autophagy and progression of gliomas via upregulating HMGB1.
Zhao M; Zhang Y; Jiang Y; Wang K; Wang X; Zhou D; Wang Y; Yu R; Zhou X
J Exp Clin Cancer Res; 2021 Mar; 40(1):99. PubMed ID: 33726796
[TBL] [Abstract][Full Text] [Related]
15. Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway.
Zhu M; Niu J; Jiang J; Dong T; Chen Y; Yang X; Liu P
Life Sci; 2022 Mar; 293():120358. PubMed ID: 35092731
[TBL] [Abstract][Full Text] [Related]
16. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
18. Fraxinellone inhibits progression of glioblastoma via regulating the SIRT3 signaling pathway.
Shi J; Sun S; Xing S; Huang C; Huang Y; Wang Q; Xue X; Chen Z; Wang Y; Huang Z
Biomed Pharmacother; 2022 Sep; 153():113416. PubMed ID: 36076484
[TBL] [Abstract][Full Text] [Related]
19. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CASP5 promotes the malignant phenotypes of human glioblastoma multiforme.
Zhou Y; Dai W; Wang H; Pan H; Wang Q
Biochem Biophys Res Commun; 2018 Jun; 500(4):966-972. PubMed ID: 29715460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
